When was Vita 34 AG stock made available for the first time to the public?

The IPO Date for Vita 34 AG is 2007-03-27. On this 2007-03-27, Vita 34 AG stock was made publicly available.

Where is the headquarters of Vita 34 AG stock?

Headquarters information for Vita 34 AG is currently unavailable. We'll update this as soon as it's available.

What industry does Vita 34 AG belong to?

The Vita 34 AG belongs to Medical - Care Facilities.

Vita 34 AG

V3V.DE•XETRA

Healthcare

Medical - Care Facilities

€4.18

€0.00(0.00%)

Vita 34 AG (V3V.DE) Company Profile & Overview

Explore Vita 34 AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Vita 34 AG (V3V.DE) Company Profile & Overview

VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.

SectorHealthcare

IndustryMedical - Care Facilities

CEOJakub Julian Baran

Contact Information

https://www.vita34.de

49 341 48792 40

Deutscher Platz 5a, Leipzig, 04103

Company Facts

783 Employees

IPO DateMar 27, 2007

CountryDE

Actively Trading

Frequently Asked Questions

;